Loading…

Ophthalmic Administration of a DNA Plasmid Harboring the Murine Tph2 Gene: Evidence of Recombinant Tph2-FLAG in Brain Structures

Tryptophan hydroxylase-type 2 (Tph2) is the first rate-limiting step in the biosynthesis of serotonin (5-HT) in the brain. The ophthalmic administration (Op-Ad) is a non-invasive method that allows delivering genetic vehicles through the eye and reaches the brain. Here, the murine Tph2 gene was clon...

Full description

Saved in:
Bibliographic Details
Published in:Molecular biotechnology 2020-03, Vol.62 (3), p.200-209
Main Authors: Tesoro-Cruz, Emiliano, Oviedo, Norma, Manuel-Apolinar, Leticia, Orozco-Suárez, Sandra, Pérez de la Mora, Miguel, Martínez-Pérez, Gloria, Guerra-Castillo, Francisco Xavier, Aguirre-Alvarado, Charmina, Bekker-Méndez, Vilma Carolina
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c374t-8b510fe452d6ec98fc17c0876b67fda7a50a0ba29ee708ae90ac8cc0308392733
cites cdi_FETCH-LOGICAL-c374t-8b510fe452d6ec98fc17c0876b67fda7a50a0ba29ee708ae90ac8cc0308392733
container_end_page 209
container_issue 3
container_start_page 200
container_title Molecular biotechnology
container_volume 62
creator Tesoro-Cruz, Emiliano
Oviedo, Norma
Manuel-Apolinar, Leticia
Orozco-Suárez, Sandra
Pérez de la Mora, Miguel
Martínez-Pérez, Gloria
Guerra-Castillo, Francisco Xavier
Aguirre-Alvarado, Charmina
Bekker-Méndez, Vilma Carolina
description Tryptophan hydroxylase-type 2 (Tph2) is the first rate-limiting step in the biosynthesis of serotonin (5-HT) in the brain. The ophthalmic administration (Op-Ad) is a non-invasive method that allows delivering genetic vehicles through the eye and reaches the brain. Here, the murine Tph2 gene was cloned in a non-viral vector (pIRES-hrGFP-1a), generating pIRES-hrGFP-1a-Tph2, plus the FLAG-tag. Recombinant Tph2-FLAG was detected and tested in vitro and in vivo , where 25 μg of pIRES-hrGFP-1a-Tph2-FLAG was Op-Ad to mice. The construct was capable of expressing and producing the recombinant Tph2-FLAG in vitro and in vivo . The in vivo assays showed that the construct efficiently crossed the Hemato-Ocular Barrier and the Blood–Brain Barrier, reached brain cells, passed the optical nerves, and transcribed mRNA-Tph2-FLAG in different brain areas. The recombinant Tph2-FLAG was observed in amygdala and brainstem, mainly in raphe dorsal and medial. Relative Tph2 expression of threefold over basal level was recorded three days after Op-Ad. These results demonstrated that pIRES-hrGFP-Tph2-FLAG, administrated through the eyes was capable of reaching the brain, transcribing, and translating Tph2 . In conclusion, this study showed the feasibility of delivering therapeutic genes, such as the Tph2, the first enzyme, rate-limiting step in the 5-HT biosynthesis.
doi_str_mv 10.1007/s12033-020-00239-x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_236774672</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1940531201</sourcerecordid><originalsourceid>FETCH-LOGICAL-c374t-8b510fe452d6ec98fc17c0876b67fda7a50a0ba29ee708ae90ac8cc0308392733</originalsourceid><addsrcrecordid>eNp9kMtu2zAQRYmgQfPqD2RREN0zGZGWKHXnOrETwG2KPNYERY1qBhalkFSQ7PrppWOn3XVDzuLcO5hDyGkGZxmAPA8ZByEYcGAAXFTsZY8cZnleMRCQf0gzSMEKKPMDchTCY4KyfCI-kgORglDw8pD8vhlWcaXXnTV02nTW2RC9jrZ3tG-pphc_pvTnWofONvRK-7r31v2icYX0-5hGpPfDitMFOvxKL59tg87gJnmLpu9q67SLbwibL6cLah395nV676IfTRw9hhOy3-p1wE-7_5g8zC_vZ1dsebO4nk2XzAg5iays8wxanOS8KdBUZWsyaaCURV3IttFS56Ch1rxClFBqrECb0ph0ZikqLoU4Jl-2vYPvn0YMUT32o3dppeKikHJSSJ4gvoWM70Pw2KrB2077V5WB2jhXW-cqOVdvztVLCn3eNY91h83fyLvkBIgtEIaNPfT_Vv-n9g-2Yoxh</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>236774672</pqid></control><display><type>article</type><title>Ophthalmic Administration of a DNA Plasmid Harboring the Murine Tph2 Gene: Evidence of Recombinant Tph2-FLAG in Brain Structures</title><source>Springer Nature</source><creator>Tesoro-Cruz, Emiliano ; Oviedo, Norma ; Manuel-Apolinar, Leticia ; Orozco-Suárez, Sandra ; Pérez de la Mora, Miguel ; Martínez-Pérez, Gloria ; Guerra-Castillo, Francisco Xavier ; Aguirre-Alvarado, Charmina ; Bekker-Méndez, Vilma Carolina</creator><creatorcontrib>Tesoro-Cruz, Emiliano ; Oviedo, Norma ; Manuel-Apolinar, Leticia ; Orozco-Suárez, Sandra ; Pérez de la Mora, Miguel ; Martínez-Pérez, Gloria ; Guerra-Castillo, Francisco Xavier ; Aguirre-Alvarado, Charmina ; Bekker-Méndez, Vilma Carolina</creatorcontrib><description>Tryptophan hydroxylase-type 2 (Tph2) is the first rate-limiting step in the biosynthesis of serotonin (5-HT) in the brain. The ophthalmic administration (Op-Ad) is a non-invasive method that allows delivering genetic vehicles through the eye and reaches the brain. Here, the murine Tph2 gene was cloned in a non-viral vector (pIRES-hrGFP-1a), generating pIRES-hrGFP-1a-Tph2, plus the FLAG-tag. Recombinant Tph2-FLAG was detected and tested in vitro and in vivo , where 25 μg of pIRES-hrGFP-1a-Tph2-FLAG was Op-Ad to mice. The construct was capable of expressing and producing the recombinant Tph2-FLAG in vitro and in vivo . The in vivo assays showed that the construct efficiently crossed the Hemato-Ocular Barrier and the Blood–Brain Barrier, reached brain cells, passed the optical nerves, and transcribed mRNA-Tph2-FLAG in different brain areas. The recombinant Tph2-FLAG was observed in amygdala and brainstem, mainly in raphe dorsal and medial. Relative Tph2 expression of threefold over basal level was recorded three days after Op-Ad. These results demonstrated that pIRES-hrGFP-Tph2-FLAG, administrated through the eyes was capable of reaching the brain, transcribing, and translating Tph2 . In conclusion, this study showed the feasibility of delivering therapeutic genes, such as the Tph2, the first enzyme, rate-limiting step in the 5-HT biosynthesis.</description><identifier>ISSN: 1073-6085</identifier><identifier>EISSN: 1559-0305</identifier><identifier>DOI: 10.1007/s12033-020-00239-x</identifier><identifier>PMID: 32030628</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Administration, Ophthalmic ; Amygdala ; Animals ; Biochemistry ; Biological Techniques ; Biosynthesis ; Biotechnology ; Blood-brain barrier ; Blood-Brain Barrier - cytology ; Blood-Brain Barrier - metabolism ; Brain ; Brain stem ; Cell Biology ; Chemistry ; Chemistry and Materials Science ; Constraining ; Deoxyribonucleic acid ; DNA ; Eye (anatomy) ; Feasibility studies ; Flags ; Gene Expression ; HEK293 Cells ; Human Genetics ; Humans ; Hydroxylase ; Male ; Mice ; Mice, Inbred BALB C ; mRNA ; Nerves ; Optic Nerve - cytology ; Optic Nerve - metabolism ; Original Paper ; Plasmids - genetics ; Plasmids - pharmacokinetics ; Plasmids - pharmacology ; Protein Science ; Recombinant ; Recombinant Fusion Proteins - biosynthesis ; Recombinant Fusion Proteins - genetics ; Serotonin ; Tryptophan ; Tryptophan hydroxylase ; Tryptophan Hydroxylase - biosynthesis ; Tryptophan Hydroxylase - genetics</subject><ispartof>Molecular biotechnology, 2020-03, Vol.62 (3), p.200-209</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2020</rights><rights>Molecular Biotechnology is a copyright of Springer, (2020). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c374t-8b510fe452d6ec98fc17c0876b67fda7a50a0ba29ee708ae90ac8cc0308392733</citedby><cites>FETCH-LOGICAL-c374t-8b510fe452d6ec98fc17c0876b67fda7a50a0ba29ee708ae90ac8cc0308392733</cites><orcidid>0000-0001-8877-8439</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32030628$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tesoro-Cruz, Emiliano</creatorcontrib><creatorcontrib>Oviedo, Norma</creatorcontrib><creatorcontrib>Manuel-Apolinar, Leticia</creatorcontrib><creatorcontrib>Orozco-Suárez, Sandra</creatorcontrib><creatorcontrib>Pérez de la Mora, Miguel</creatorcontrib><creatorcontrib>Martínez-Pérez, Gloria</creatorcontrib><creatorcontrib>Guerra-Castillo, Francisco Xavier</creatorcontrib><creatorcontrib>Aguirre-Alvarado, Charmina</creatorcontrib><creatorcontrib>Bekker-Méndez, Vilma Carolina</creatorcontrib><title>Ophthalmic Administration of a DNA Plasmid Harboring the Murine Tph2 Gene: Evidence of Recombinant Tph2-FLAG in Brain Structures</title><title>Molecular biotechnology</title><addtitle>Mol Biotechnol</addtitle><addtitle>Mol Biotechnol</addtitle><description>Tryptophan hydroxylase-type 2 (Tph2) is the first rate-limiting step in the biosynthesis of serotonin (5-HT) in the brain. The ophthalmic administration (Op-Ad) is a non-invasive method that allows delivering genetic vehicles through the eye and reaches the brain. Here, the murine Tph2 gene was cloned in a non-viral vector (pIRES-hrGFP-1a), generating pIRES-hrGFP-1a-Tph2, plus the FLAG-tag. Recombinant Tph2-FLAG was detected and tested in vitro and in vivo , where 25 μg of pIRES-hrGFP-1a-Tph2-FLAG was Op-Ad to mice. The construct was capable of expressing and producing the recombinant Tph2-FLAG in vitro and in vivo . The in vivo assays showed that the construct efficiently crossed the Hemato-Ocular Barrier and the Blood–Brain Barrier, reached brain cells, passed the optical nerves, and transcribed mRNA-Tph2-FLAG in different brain areas. The recombinant Tph2-FLAG was observed in amygdala and brainstem, mainly in raphe dorsal and medial. Relative Tph2 expression of threefold over basal level was recorded three days after Op-Ad. These results demonstrated that pIRES-hrGFP-Tph2-FLAG, administrated through the eyes was capable of reaching the brain, transcribing, and translating Tph2 . In conclusion, this study showed the feasibility of delivering therapeutic genes, such as the Tph2, the first enzyme, rate-limiting step in the 5-HT biosynthesis.</description><subject>Administration, Ophthalmic</subject><subject>Amygdala</subject><subject>Animals</subject><subject>Biochemistry</subject><subject>Biological Techniques</subject><subject>Biosynthesis</subject><subject>Biotechnology</subject><subject>Blood-brain barrier</subject><subject>Blood-Brain Barrier - cytology</subject><subject>Blood-Brain Barrier - metabolism</subject><subject>Brain</subject><subject>Brain stem</subject><subject>Cell Biology</subject><subject>Chemistry</subject><subject>Chemistry and Materials Science</subject><subject>Constraining</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>Eye (anatomy)</subject><subject>Feasibility studies</subject><subject>Flags</subject><subject>Gene Expression</subject><subject>HEK293 Cells</subject><subject>Human Genetics</subject><subject>Humans</subject><subject>Hydroxylase</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>mRNA</subject><subject>Nerves</subject><subject>Optic Nerve - cytology</subject><subject>Optic Nerve - metabolism</subject><subject>Original Paper</subject><subject>Plasmids - genetics</subject><subject>Plasmids - pharmacokinetics</subject><subject>Plasmids - pharmacology</subject><subject>Protein Science</subject><subject>Recombinant</subject><subject>Recombinant Fusion Proteins - biosynthesis</subject><subject>Recombinant Fusion Proteins - genetics</subject><subject>Serotonin</subject><subject>Tryptophan</subject><subject>Tryptophan hydroxylase</subject><subject>Tryptophan Hydroxylase - biosynthesis</subject><subject>Tryptophan Hydroxylase - genetics</subject><issn>1073-6085</issn><issn>1559-0305</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kMtu2zAQRYmgQfPqD2RREN0zGZGWKHXnOrETwG2KPNYERY1qBhalkFSQ7PrppWOn3XVDzuLcO5hDyGkGZxmAPA8ZByEYcGAAXFTsZY8cZnleMRCQf0gzSMEKKPMDchTCY4KyfCI-kgORglDw8pD8vhlWcaXXnTV02nTW2RC9jrZ3tG-pphc_pvTnWofONvRK-7r31v2icYX0-5hGpPfDitMFOvxKL59tg87gJnmLpu9q67SLbwibL6cLah395nV676IfTRw9hhOy3-p1wE-7_5g8zC_vZ1dsebO4nk2XzAg5iays8wxanOS8KdBUZWsyaaCURV3IttFS56Ch1rxClFBqrECb0ph0ZikqLoU4Jl-2vYPvn0YMUT32o3dppeKikHJSSJ4gvoWM70Pw2KrB2077V5WB2jhXW-cqOVdvztVLCn3eNY91h83fyLvkBIgtEIaNPfT_Vv-n9g-2Yoxh</recordid><startdate>20200301</startdate><enddate>20200301</enddate><creator>Tesoro-Cruz, Emiliano</creator><creator>Oviedo, Norma</creator><creator>Manuel-Apolinar, Leticia</creator><creator>Orozco-Suárez, Sandra</creator><creator>Pérez de la Mora, Miguel</creator><creator>Martínez-Pérez, Gloria</creator><creator>Guerra-Castillo, Francisco Xavier</creator><creator>Aguirre-Alvarado, Charmina</creator><creator>Bekker-Méndez, Vilma Carolina</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>Q9U</scope><orcidid>https://orcid.org/0000-0001-8877-8439</orcidid></search><sort><creationdate>20200301</creationdate><title>Ophthalmic Administration of a DNA Plasmid Harboring the Murine Tph2 Gene: Evidence of Recombinant Tph2-FLAG in Brain Structures</title><author>Tesoro-Cruz, Emiliano ; Oviedo, Norma ; Manuel-Apolinar, Leticia ; Orozco-Suárez, Sandra ; Pérez de la Mora, Miguel ; Martínez-Pérez, Gloria ; Guerra-Castillo, Francisco Xavier ; Aguirre-Alvarado, Charmina ; Bekker-Méndez, Vilma Carolina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c374t-8b510fe452d6ec98fc17c0876b67fda7a50a0ba29ee708ae90ac8cc0308392733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Administration, Ophthalmic</topic><topic>Amygdala</topic><topic>Animals</topic><topic>Biochemistry</topic><topic>Biological Techniques</topic><topic>Biosynthesis</topic><topic>Biotechnology</topic><topic>Blood-brain barrier</topic><topic>Blood-Brain Barrier - cytology</topic><topic>Blood-Brain Barrier - metabolism</topic><topic>Brain</topic><topic>Brain stem</topic><topic>Cell Biology</topic><topic>Chemistry</topic><topic>Chemistry and Materials Science</topic><topic>Constraining</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>Eye (anatomy)</topic><topic>Feasibility studies</topic><topic>Flags</topic><topic>Gene Expression</topic><topic>HEK293 Cells</topic><topic>Human Genetics</topic><topic>Humans</topic><topic>Hydroxylase</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>mRNA</topic><topic>Nerves</topic><topic>Optic Nerve - cytology</topic><topic>Optic Nerve - metabolism</topic><topic>Original Paper</topic><topic>Plasmids - genetics</topic><topic>Plasmids - pharmacokinetics</topic><topic>Plasmids - pharmacology</topic><topic>Protein Science</topic><topic>Recombinant</topic><topic>Recombinant Fusion Proteins - biosynthesis</topic><topic>Recombinant Fusion Proteins - genetics</topic><topic>Serotonin</topic><topic>Tryptophan</topic><topic>Tryptophan hydroxylase</topic><topic>Tryptophan Hydroxylase - biosynthesis</topic><topic>Tryptophan Hydroxylase - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tesoro-Cruz, Emiliano</creatorcontrib><creatorcontrib>Oviedo, Norma</creatorcontrib><creatorcontrib>Manuel-Apolinar, Leticia</creatorcontrib><creatorcontrib>Orozco-Suárez, Sandra</creatorcontrib><creatorcontrib>Pérez de la Mora, Miguel</creatorcontrib><creatorcontrib>Martínez-Pérez, Gloria</creatorcontrib><creatorcontrib>Guerra-Castillo, Francisco Xavier</creatorcontrib><creatorcontrib>Aguirre-Alvarado, Charmina</creatorcontrib><creatorcontrib>Bekker-Méndez, Vilma Carolina</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health Medical collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Science Journals</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>Engineering Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering collection</collection><collection>ProQuest Central Basic</collection><jtitle>Molecular biotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tesoro-Cruz, Emiliano</au><au>Oviedo, Norma</au><au>Manuel-Apolinar, Leticia</au><au>Orozco-Suárez, Sandra</au><au>Pérez de la Mora, Miguel</au><au>Martínez-Pérez, Gloria</au><au>Guerra-Castillo, Francisco Xavier</au><au>Aguirre-Alvarado, Charmina</au><au>Bekker-Méndez, Vilma Carolina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ophthalmic Administration of a DNA Plasmid Harboring the Murine Tph2 Gene: Evidence of Recombinant Tph2-FLAG in Brain Structures</atitle><jtitle>Molecular biotechnology</jtitle><stitle>Mol Biotechnol</stitle><addtitle>Mol Biotechnol</addtitle><date>2020-03-01</date><risdate>2020</risdate><volume>62</volume><issue>3</issue><spage>200</spage><epage>209</epage><pages>200-209</pages><issn>1073-6085</issn><eissn>1559-0305</eissn><abstract>Tryptophan hydroxylase-type 2 (Tph2) is the first rate-limiting step in the biosynthesis of serotonin (5-HT) in the brain. The ophthalmic administration (Op-Ad) is a non-invasive method that allows delivering genetic vehicles through the eye and reaches the brain. Here, the murine Tph2 gene was cloned in a non-viral vector (pIRES-hrGFP-1a), generating pIRES-hrGFP-1a-Tph2, plus the FLAG-tag. Recombinant Tph2-FLAG was detected and tested in vitro and in vivo , where 25 μg of pIRES-hrGFP-1a-Tph2-FLAG was Op-Ad to mice. The construct was capable of expressing and producing the recombinant Tph2-FLAG in vitro and in vivo . The in vivo assays showed that the construct efficiently crossed the Hemato-Ocular Barrier and the Blood–Brain Barrier, reached brain cells, passed the optical nerves, and transcribed mRNA-Tph2-FLAG in different brain areas. The recombinant Tph2-FLAG was observed in amygdala and brainstem, mainly in raphe dorsal and medial. Relative Tph2 expression of threefold over basal level was recorded three days after Op-Ad. These results demonstrated that pIRES-hrGFP-Tph2-FLAG, administrated through the eyes was capable of reaching the brain, transcribing, and translating Tph2 . In conclusion, this study showed the feasibility of delivering therapeutic genes, such as the Tph2, the first enzyme, rate-limiting step in the 5-HT biosynthesis.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>32030628</pmid><doi>10.1007/s12033-020-00239-x</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0001-8877-8439</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1073-6085
ispartof Molecular biotechnology, 2020-03, Vol.62 (3), p.200-209
issn 1073-6085
1559-0305
language eng
recordid cdi_proquest_journals_236774672
source Springer Nature
subjects Administration, Ophthalmic
Amygdala
Animals
Biochemistry
Biological Techniques
Biosynthesis
Biotechnology
Blood-brain barrier
Blood-Brain Barrier - cytology
Blood-Brain Barrier - metabolism
Brain
Brain stem
Cell Biology
Chemistry
Chemistry and Materials Science
Constraining
Deoxyribonucleic acid
DNA
Eye (anatomy)
Feasibility studies
Flags
Gene Expression
HEK293 Cells
Human Genetics
Humans
Hydroxylase
Male
Mice
Mice, Inbred BALB C
mRNA
Nerves
Optic Nerve - cytology
Optic Nerve - metabolism
Original Paper
Plasmids - genetics
Plasmids - pharmacokinetics
Plasmids - pharmacology
Protein Science
Recombinant
Recombinant Fusion Proteins - biosynthesis
Recombinant Fusion Proteins - genetics
Serotonin
Tryptophan
Tryptophan hydroxylase
Tryptophan Hydroxylase - biosynthesis
Tryptophan Hydroxylase - genetics
title Ophthalmic Administration of a DNA Plasmid Harboring the Murine Tph2 Gene: Evidence of Recombinant Tph2-FLAG in Brain Structures
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T13%3A24%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ophthalmic%20Administration%20of%20a%20DNA%20Plasmid%20Harboring%20the%20Murine%20Tph2%20Gene:%20Evidence%20of%20Recombinant%20Tph2-FLAG%20in%20Brain%20Structures&rft.jtitle=Molecular%20biotechnology&rft.au=Tesoro-Cruz,%20Emiliano&rft.date=2020-03-01&rft.volume=62&rft.issue=3&rft.spage=200&rft.epage=209&rft.pages=200-209&rft.issn=1073-6085&rft.eissn=1559-0305&rft_id=info:doi/10.1007/s12033-020-00239-x&rft_dat=%3Cproquest_cross%3E1940531201%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c374t-8b510fe452d6ec98fc17c0876b67fda7a50a0ba29ee708ae90ac8cc0308392733%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=236774672&rft_id=info:pmid/32030628&rfr_iscdi=true